Aziz F, van Wijnen A J, Stein J L, Stein G S
Department of Cell Biology, University of Massachusetts Medical Center, Worcester 01655, USA.
J Cell Physiol. 1998 Dec;177(3):453-64. doi: 10.1002/(SICI)1097-4652(199812)177:3<453::AID-JCP8>3.0.CO;2-F.
Cell cycle control of histone H4 gene transcription is mediated by the multipartite promoter domain H4-Site II, which supports transcriptional activation at the G1/S phase transition and modulates basal H4 gene transcription. Proliferation-specific transcription is determined by the integrated activities of three distinct promoter factors interacting with H4-Site II: the interferon regulatory factor IRF-2 (synonymous with HiNF-M), HiNF-D (a complex between the homeodomain protein CDP-cut and the cell cycle mediators CDC2, cyclin A and pRB), as well as HiNF-P/H4TF-2. However, the contribution of HiNF-D to the enhancement and/or suppression of H4 gene transcription at specific cell cycle stages remains to be established. We used a panel of synchronized HeLa S3 cell lines containing stably integrated H4 promoter/CAT reporter gene constructs with mutations in H4-Site II. The temporal regulation of CAT mRNA accumulation under the control of the H4 promoter was analyzed by RNase protection analysis. Our main finding is that mutation of the HiNF-D/CDP-cut binding site alters the timing of histone gene activation during the cell cycle. Furthermore, our data indicate that HiNF-P/H4TF-2 may functionally compensate for HiNF-M/IRF-2 at Site II to regulate histone H4 gene transcription in HeLa S3 cervical carcinoma cells during early S phase. We postulate that HiNF-D (CDP-cut/cyclin A/CDC2/pRB containing complex) promotes HiNF-M/IRF-2 (and/or HiNF-P/H4TF-2) dependent histone H4 gene activation at the G1/S phase transition and attenuates H4 gene transcription at later cell cycle stages. The mechanistic division in the gene regulatory functions of the three H4-Site II binding proteins may ensure that histone H4 gene expression is stringently coupled with the onset of S phase in response to growth factor/cytokine-induced cell cycle progression.
组蛋白H4基因转录的细胞周期控制由多部分启动子结构域H4 - 位点II介导,该结构域在G1/S期转变时支持转录激活,并调节H4基因的基础转录。增殖特异性转录由与H4 - 位点II相互作用的三种不同启动子因子的综合活性决定:干扰素调节因子IRF - 2(与HiNF - M同义)、HiNF - D(同源结构域蛋白CDP - cut与细胞周期调节因子CDC2、细胞周期蛋白A和pRB之间的复合物)以及HiNF - P/H4TF - 2。然而,HiNF - D在特定细胞周期阶段对H4基因转录增强和/或抑制的作用仍有待确定。我们使用了一组稳定整合了H4启动子/CAT报告基因构建体且H4 - 位点II有突变的同步化HeLa S3细胞系。通过核糖核酸酶保护分析来分析H4启动子控制下CAT mRNA积累的时间调控。我们的主要发现是,HiNF - D/CDP - cut结合位点的突变改变了细胞周期中组蛋白基因激活的时间。此外,我们的数据表明,在S期早期,HiNF - P/H4TF - 2可能在位点II功能上补偿HiNF - M/IRF - 2,以调节HeLa S3宫颈癌细胞中的组蛋白H4基因转录。我们推测,HiNF - D(包含CDP - cut/细胞周期蛋白A/CDC2/pRB的复合物)在G1/S期转变时促进HiNF - M/IRF - 2(和/或HiNF - P/H4TF - 2)依赖的组蛋白H4基因激活,并在细胞周期后期减弱H4基因转录。三种H4 - 位点II结合蛋白在基因调控功能上的机制划分可能确保组蛋白H4基因表达与生长因子/细胞因子诱导的细胞周期进程中S期的开始紧密耦合。